BioNTech’s mRNA vaccine for head and neck cancer missed the first of two primary endpoints in a pivotal trial. https://endpoints.news/biontechs-head-and-neck-cancer-vaccine-misses-first-of-two-goals/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial